Dystrophinopathy Research Digest
Dystrophinopathy Research Digest
Welcome to the Dystrophinopathy Research Digest, a monthly roundup of recent publications, reviews, commentaries, and other noteworthy articles relevant to Becker and Duchenne muscular dystrophy (BIND) research.
This digest is designed to help researchers, clinicians, patients, advocates, and other members of the community stay informed about developments across the rapidly evolving dystrophinopathy landscape. Importantly, the digest highlights research from the wider international field, not only work produced by BIND members, providing a broader perspective on scientific advances, emerging themes, and ongoing challenges.
Explore the links below to access individual digest articles and discover the latest insights shaping dystrophinopathy research.
Digest: September 2026
From research to screening: the BIND Screener Miranda et al.
Brain-related comorbidities are an important but often under-recognised aspect of Duchenne muscular dystrophy. The BIND Consortium has developed the BIND Screener, a brief questionnaire designed to help identify individuals who may be experiencing difficulties across a range of cognitive, behavioural, emotional and neurodevelopmental domains… more->
Digest: June 2026
Task-based effective connectivity finds alterations in frontoparietal network in Duchenne muscular dystrophy. Thangarajh et al. Duchenne muscular dystrophy is best known for its effects on muscles, but it can also affect learning, attention, and memory. In this study, researchers used brain scans to explore how different parts of the brain work together during a memory task… more >
Digest: August 2026
Understanding the neurobehavioural impact of Duchenne Muscular Dystrophy: A multi centre European study Kolesnik et al. Duchenne muscular dystrophy (DMD) is primarily known for its effects on muscles, but it can also affect how children and young people think, learn, communicate and manage emotions and behaviour. However, estimates of how common these difficulties are have varied considerably between previous studies.… more->
Digest: July 2026
Why newborn screening matters for Duchenne muscular dystrophy Newborn screening has transformed the outlook for several rare genetic diseases by enabling diagnosis before symptoms appear. Following the announcement that all newborns in England will be screened for spinal muscular atrophy (SMA) from 2027, clinicians and patient advocates are calling for …. more >
